Hemodynamics, fluids & transfusion

Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: Acute myocardial infarction (AMI) and Non-AMI

Ann Intensive CarePublished Retrospective cohort study

Main finding · All-cause mortalityResult — go to the resultAdjusted hazard ratio 0.69 95% CI 0.60–0.78

Authors' conclusion

In-hospital AMI-CS survivors had an increased risk of CV rehospitalization and 30-day mortality, whereas those with non-AMI-CS had a greater mortality risk after 1-year follow-up.

Study context

Population
In-hospital survivors of cardiogenic shock, Taiwan National Health Insurance Research Database42.4% AMI-CS, 57.6% non-AMI-CS
Participants
16,582 survivors
Exposure
Non-AMI-CS vs AMI-CS in-hospital survivors
Outcome
All-cause mortality
Methodological detailsnationwide database, multivariable Cox regression
  • Nationwide database
  • Multivariable Cox regression

Main finding

As reported in the abstract

Adjusted hazard ratio

0.69

95% CI 0.60–0.78

non-AMI-CS vs AMI-CS
aHR 0.69 (95% CI 0.60–0.78)

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)
CV mortality0.65 (0.54–0.78)
All-cause mortality after 1 year · after one year1.13 (1.03–1.25)
CV mortality after 1 year · after one year1.27 (1.09–1.49)
CV rehospitalization, entire observation period0.80 (0.76–0.84)

Overall mortality and rehospitalization, all cardiogenic shock (CS) survivors

Mortality at 30 days
7.0%
Rehospitalization at 30 days
22.1%
Mortality at 1 year
24.5%
Rehospitalization at 1 year
58.2%
Mortality at 3 years
38.9%
Rehospitalization at 3 years
73.0%

Cardiovascular (CV) rehospitalization, entire observation period

Reversal not observed in all-cause and CV rehospitalization

Original publication

Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI. Ann Intensive Care. Published 12 May 2024. doi:10.1186/s13613-024-01305-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.